Скачать или смотреть Deep Thoughts with GIT Mom – RSV

The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against RSV. The vaccine would be given during late pregnancy to reduce the risk of RSV infection among newborns. RSV, a common respiratory illness, can be deadly for infants because of their susceptibility to bronchiolitis, inflammation of the smallest airways that makes it hard for babies to breathe, is a common cause of pneumonia in babies and the leading cause of infant hospitalizations.

The vaccine won't be available on pharmacy shelves for pregnant women immediately. It is still awaiting an evaluation from an expert panel at the Centers for Disease Control and Prevention, and the CDC director's sign-off -- a regulatory process that could take months.
67% of infants with an RSV infection may require hospitalization, and every year the virus leads to 58,000 to 80,000 hospitalized children less than 5 years old. As many as 300 children under the age of five die from RSV every year.

The idea behind the maternal vaccine is that when given during the third trimester of pregnancy, there's enough time to build immunity against RSV and pass it along to the baby before birth. This immunity won't last forever but can help protect the youngest babies when they are the most vulnerable in the first six months of life.

Experts say that any tool to prevent severe infection from RSV benefits babies because there is no specific treatment for this virus other than supportive care after the virus is contracted.

@GITMom Subscribe: https://bit.ly/subscribetogitmom

Follow GIT Mom:
WEBSITE ➤ https://www.gitmom.com/
INSTAGRAM ➤   / gitmom  
FACEBOOK ➤   / gitmom  

#GITMom #reactionvideo #GITTips #parentinghacks #momMEtime